课题基金 / 基金详情

Organelle Dysfunction and Apoptosis in Liver Epithelia

Organelle Dysfunction and Apoptosis in Liver Epithelia
肝上皮细胞器功能障碍和细胞凋亡
批准号:
6942769
负责人:
GREGORY J. GORES
金额:
$24.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-05-31

项目摘要

项目成果

GREGORY J. GORES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this proposal is to define the cellular mechanisms culminating in lethal liver cell injury. Because of the importance of tumor necrosis factor-alpha (TNF-alpha) in human liver injury, our program is working on the cellular and subcellular mechanisms causing liver injury by this cytokine. Specifically, our long-term objectives are to understand the mechanisms involved in TNF-alpha-mediated hepatocyte apoptosis. Based on extensive preliminary data, we propose the novel CENTRAL HYPOTHESIS that TNF-alpha signals selective lysosomal permeabilization resulting in cathepsin B release into the cytosol, where it initiates mitochondrial dysfunction resulting in apoptosis and liver injury. We will now employ current and complementary, molecular, biochemical and cell biological approaches to ascertain how TNF-alpha triggers this unexplored pathway of apoptosis. Our proposal has three SPECIFIC AIMS. FIRST, we will directly test the hypothesis that TNF-alpha signal lysosomal permeabilization: a) by activating neutral sphingomyelinases through the adaptor protein FAN (factor associated with neutral sphingomyelinase) with subsequent sphingosine generation; and b) by a process dependent upon intra-lysosomal cathepsin B (i.e., cathepsin B-dependent cathepsin B release). SECOND, we will test the hypothesis that cytosolic cathepsin B mediates apoptosis: a) by activating the mitochondrial pathway of apoptosis; and b) by cleaving the proapoptotic member of the Bcl-2 family Bid, resulting in its activation and translocation to mitochondria where it induces cytochrome c release. FINALLY, we will test the hypothesis that cathepsin B mediates liver injury such that: a) cathepsin B knockout mice are resistant to liver injury following endogenous stimulation of TNF-alpha in the bile duct-ligated mouse; and b) cathepsin B knockout mice have reduced parameters of liver fibrosis following bile duct ligation. The proposal is innovative, technically and conceptually, as it tests new concepts for TNF-alpha mediated liver injury and apoptosis in general using sophisticated technologies. The significance of the information generated is that it will provide a framework for the potential development of novel therapeutic strategies effective in attenuating human liver injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cholestatic Liver Injury
  • 批准号:
    10372002
  • 项目类别:
  • 资助金额:
    $35.78万
  • 财政年份:
    2020
  • 负责人:
    GREGORY J. GORES
  • 依托单位:
Cholestatic Liver Injury
  • 批准号:
    10588191
  • 项目类别:
  • 资助金额:
    $35.78万
  • 财政年份:
    2020
  • 负责人:
    GREGORY J. GORES
  • 依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
  • 批准号:
    10468830
  • 项目类别:
  • 资助金额:
    $29.79万
  • 财政年份:
    2018
  • 负责人:
    GREGORY J. GORES
  • 依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
  • 批准号:
    10006083
  • 项目类别:
  • 资助金额:
    $33.81万
  • 财政年份:
    2018
  • 负责人:
    GREGORY J. GORES
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: